A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity

por Castoldi, R, Ecker, V, Wiehle, L, Majety, M, Busl-Schuller, R, Asmussen, M, Nopora, A, Jucknischke, U, Osl, F, Kobold, S, Scheuer, W, Venturi, M, Klein, C, Niederfellner, G, Sustmann, C
Publicado 2013